Daniel Dias Rufino Arcanjo Selected Research

Daniel Dias Rufino Arcanjo Research Topics

Disease

5	Infections 01/2023 - 09/2017
4	Dyslipidemias (Dyslipidemia) 01/2024 - 02/2019
3	Diabetes Mellitus 01/2023 - 04/2022
2	Leishmaniasis 01/2023 - 09/2017
2	Stomach Ulcer (Gastric Ulcer) 01/2023 - 01/2022
2	Atherosclerosis 01/2022 - 01/2021
2	Hypercholesterolemia 01/2022 - 01/2022
2	Hypertension (High Blood Pressure) 01/2022 - 09/2020
2	Schistosomiasis (Bilharziasis) 05/2021 - 04/2017
1	COVID-19 08/2023
1	Chronic Disease (Chronic Diseases) 06/2023
1	Inflammation (Inflammations) 06/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2023
1	Ulcer 01/2023
1	Ischemia 01/2023
1	Insulin Resistance 10/2022
1	Hyperglycemia 10/2022
1	Cystitis 05/2022
1	Hemorrhage 05/2022
1	Hemorrhagic Cystitis 05/2022
1	Edema (Dropsy) 05/2022
1	Weight Gain 04/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Angina Pectoris 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Vitiligo 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Cutaneous Leishmaniasis 11/2020
1	Peripheral Arterial Disease 01/2019
1	Alcoholism (Alcohol Abuse) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Bradycardia 10/2014
1	Tachycardia (Tachyarrhythmias) 10/2014

Drug/Important Bio-Agent (IBA)

3	AcidsIBA 05/2023 - 09/2017
3	LipidsIBA 05/2023 - 02/2019
2	Fish OilsIBA 01/2024 - 01/2022
2	LycopeneIBA 06/2023 - 02/2019
2	Monoterpenes (Monoterpenoids)IBA 01/2023 - 01/2023
2	Norfloxacin FDA Link 01/2023 - 01/2022
2	menthofuranIBA 01/2023 - 01/2023
2	EnzymesIBA 12/2022 - 10/2022
2	AntioxidantsIBA 10/2022 - 05/2022
2	Blood Glucose (Blood Sugar)IBA 10/2022 - 04/2022
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2022 - 04/2022
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 01/2022
2	CholesterolIBA 01/2022 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 02/2019
2	Biomarkers (Surrogate Marker)IBA 02/2019 - 01/2017
1	Carotenoids (Carotene)IBA 06/2023
1	PolyphenolsIBA 05/2023
1	LignansIBA 05/2023
1	Volatile Oils (Essential Oils)IBA 01/2023
1	Ethanol (Ethyl Alcohol)IBA 01/2023
1	CalciumIBA 01/2023
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2023
1	Malondialdehyde (Propanedial)IBA 01/2023
1	Peroxidase (Myeloperoxidase)IBA 01/2023
1	CatalaseIBA 10/2022
1	ZincIBA 10/2022
1	Trace Elements (Biometals)IBA 10/2022
1	Mesna (Coenzyme M)FDA LinkGeneric 05/2022
1	Ifosfamide FDA LinkGeneric 05/2022
1	CytokinesIBA 05/2022
1	Hemoglobins (Hemoglobin)IBA 05/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2022
1	Transaminases (Aminotransferases)IBA 04/2022
1	Streptozocin (Streptozotocin)FDA Link 04/2022
1	Glucose (Dextrose)FDA LinkGeneric 04/2022
1	Proteins (Proteins, Gene)FDA Link 04/2022
1	Thiobarbituric Acid Reactive SubstancesIBA 04/2022
1	Docosahexaenoic AcidsIBA 01/2022
1	Cholic AcidIBA 01/2022
1	mesoglycanIBA 01/2022
1	KhellinIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Parasympatholytics (Antispasmodics)IBA 01/2022
1	Vasodilator Agents (Vasodilators)IBA 01/2022
1	ChitosanIBA 01/2022
1	visnaginIBA 01/2022
1	Antimalarials (Antimalarial Agents)IBA 05/2021
1	Antiparasitic Agents (Antiparasitics)IBA 05/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Gallic AcidIBA 11/2020
1	Ellagic AcidIBA 11/2020
1	Amphotericin B (Amphotericin)FDA LinkGeneric 11/2020
1	AcetylcholinesteraseIBA 09/2020
1	NitritesIBA 03/2020
1	exendin (9-39)IBA 01/2019
1	Therapeutic UsesIBA 09/2017
1	Immunologic Factors (Immunomodulators)IBA 09/2017
1	Praziquantel (Biltricide)FDA Link 04/2017
1	Peptides (Polypeptides)IBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2017
1	Phytotherapy (Herbal Therapy) 08/2023
1	Drug Therapy (Chemotherapy) 01/2017
1	Radiotherapy 01/2017
1	Controlled Hypotension 10/2014